Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology
SAGA Metals Announces Additional Assay Results from Drilling at Trapper North, Confirming High-Grade Mineralization at Radar Critical Minerals Project in Labrador
Providence Gold Mines Inc. Announces Final Approval of Reviewable Transaction and The La Dama de Oro Gold Property NI43 101 Report
